Literature DB >> 8938110

Characterization of the antigen-presenting cell and T cell requirements for induction of pulmonary eosinophilia in a murine model of asthma.

L E Lambert1, J S Berling, E M Kudlacz.   

Abstract

A model of allergic pulmonary inflammation is described in which the intraperitoneal injection of antigen (Ag)-pulsed cells resulted in T cell priming. Mice received two injections of 10(6) elicited peritoneal macrophages, which had been incubated with Ag for 48 hr, on Days 0 and 6, followed by an aerosol Ag challenge on Day 19. Bronchoalveolar lavage fluid harvested on Day 21 contained increased eosinophil numbers and resembled the cell influx observed following immunization with Ag in alum. Incubation of Ag-presenting cells with interferon-gamma resulted in increased expression of the costimulator molecule B7-2 and of MHC Ags, but did not enhance priming capacity. Using this system, antibodies to CD4 and CD8 were tested for their ability to block sensitization by Ag-pulsed cells. Both anti-CD4 and anti-CD8 antibodies completely blocked the airway eosinophil response following aerosol Ag challenge. This model will be very useful for characterization of the interactions between Ag-presenting cells and T cells which ultimately result in the induction of pulmonary eosinophilia.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8938110     DOI: 10.1006/clin.1996.0194

Source DB:  PubMed          Journal:  Clin Immunol Immunopathol        ISSN: 0090-1229


  2 in total

1.  Shifts in lung lymphocyte profiles correlate with the sequential development of acute allergic and chronic tolerant stages in a murine asthma model.

Authors:  C A Yiamouyiannis; C M Schramm; L Puddington; P Stengel; E Baradaran-Hosseini; W W Wolyniec; H E Whiteley; R S Thrall
Journal:  Am J Pathol       Date:  1999-06       Impact factor: 4.307

2.  Contribution of nitric oxide synthases 1, 2, and 3 to airway hyperresponsiveness and inflammation in a murine model of asthma.

Authors:  G T De Sanctis; J A MacLean; K Hamada; S Mehta; J A Scott; A Jiao; C N Yandava; L Kobzik; W W Wolyniec; A J Fabian; C S Venugopal; H Grasemann; P L Huang; J M Drazen
Journal:  J Exp Med       Date:  1999-05-17       Impact factor: 14.307

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.